Covered recipient · General Payments record
NITIN S BUTALA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2023
$17,028.28
- Reported across 692 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,500.00 | 1 |
| Travel and Lodging | $2,481.35 | 4 |
| Food and Beverage | $521.29 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $5,249.64 | 7 |
| ARGENX US, INC. | $124.22 | 1 |
| Teva Pharmaceuticals USA, Inc. | $35.53 | 2 |
| EISAI INC. | $24.42 | 1 |
| Amgen Inc. | $23.04 | 1 |
| Grifols USA, LLC | $16.76 | 1 |
| ABBVIE INC. | $15.73 | 1 |
| Alexion Pharmaceuticals, Inc. | $13.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $15.73 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996339651 | CMS |
| Alexion Pharmaceuticals, Inc. | $13.30 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1017036609 | CMS |
| Amgen Inc. | $23.04 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020046147 | CMS |
| ARGENX US, INC. | $124.22 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060432561 | CMS |
| Corium, LLC | $149.72 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987688743 | CMS |
| Corium, LLC | $191.82 | 05/10/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 987688749 | CMS |
| Corium, LLC | $1,480.60 | 05/10/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 987688751 | CMS |
| Corium, LLC | $489.00 | 05/10/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 987688753 | CMS |
| Corium, LLC | $2,500.00 | 05/31/2023 | Consulting Fee | Undisputed | 01/23/2026 | 987688713 | CMS |
| Corium, LLC | $319.93 | 06/21/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 987688729 | CMS |
| Corium, LLC | $118.57 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 990267757 | CMS |
| Eisai Inc. | $24.42 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023325791 | CMS |
| Grifols USA, LLC | $16.76 | 01/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011861911 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.71 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056681459 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.82 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056681463 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.